Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects

The monkeypox disease (MPX) outbreak of 2022 has been reported in more than one hundred countries and is becoming a global concern. Unfortunately, only a few treatments, such as tecovirimat (TCV), are available against MPX. Brincidofovir (BCV) is a United States Food and Drug Administration (USFDA)-...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mohd. Imran, Mohammed Kanan Alshammari, Mandeep Kumar Arora, Amit Kumar Dubey, Sabya Sachi Das, Mehnaz Kamal, Abdulaziz Saad Abdulrahman Alqahtani, Mohammed Ahmed Yahya Sahloly, Ahmed Hammad Alshammari, Hessah Mohammed Alhomam, Aeshah Mousa Mahzari, Abida, Ali A. Rabaan, Tafadzwa Dzinamarira
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-01-01
Colecção:	Biomedicines
Assuntos:	brincidofovir CMX001 cidofovir monkeypox smallpox Orthopoxvirus
Acesso em linha:	https://www.mdpi.com/2227-9059/11/2/278
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!